Clinical Trial Imaging Market Size, Share, Growth, Trends and Industry Analysis Report, 2018 to 2026
Growing pharmaceutical and biotechnology companies coupled with increasing investments in the field of R&D for developing new drugs to cure diseases is one of the key trends escalating clinical trial imaging market growth.
(firmenpresse) - The global clinical trial imaging market size is expected to reach USD 1.31 billion by 2026, according to a new report by Grand View Research, Inc., progressing at a CAGR of 5.8% during the forecast period. Increasing spending on research and development activities to develop new drugs and therapies to treat chronic diseases is boosting market growth.
Clinical trials assist in the development, registration, and eventually access of new drugs to patients. Imaging helps in the process of drug development by offering non-invasive evaluation of drug action and response of tumor to treatment. Functional imaging techniques are progressively being used in early phases of clinical trials to study initial effects of drug action on parts of tumor biology including metabolism, cellularity, and vascularity.
Contract Research Organizations (CROs) were the most prominent end-use segment in the market in 2017. Imaging modalities are used to determine indicators of pharmacological response to a therapy. Biomarkers and surrogate endpoints assist in obtaining quick results with good statistical power even in small sample sizes encouraging CROs to carryout multiple studies with reduced cost of operation.
The market in Asia Pacific is projected to witness swift growth during the forecast period as the number of CROs and pharmaceutical organizations in the region are increasing in recent past due to low cost of labor and public and private funding offered in countries such as India and China.
However, inaccessibility of trial protocols and poor quality of registered clinical trial data, results, and participant-level data undermined the potential benefits of clinical trial registration earlier. Nevertheless, emergence of national and regional registries and ICTRP have facilitated to overcome aforementioned barriers in APAC.
Further key findings from the report suggest:
s of trial registration to date and is likely to be supported in tackling such challenges in the near future
Themen in dieser Pressemitteilung:
clinical-trial-imaging
clinical-trial
medical-imaging
imaging
healthcare
medical-devices
medical-imaging-systems
Unternehmensinformation / Kurzprofil:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales(at)grandviewresearch.com
For More Information: www.grandviewresearch.com
Datum: 30.03.2020 - 16:31 Uhr
Sprache: Deutsch
News-ID 1557159
Anzahl Zeichen: 2823
contact information:
Contact person:
Town:
San Francisco
Phone: 1-888-202-9519
Kategorie:
Healthcare & Medical
Typ of Press Release: Financial
type of sending: send
Date of sending: 30.03.2020
Anmerkungen:
Diese Pressemitteilung wurde bisher 1076 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Clinical Trial Imaging Market Size, Share, Growth, Trends and Industry Analysis Report, 2018 to 2026
"
steht unter der journalistisch-redaktionellen Verantwortung von
Grand View Research, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
